Regeneron Pharmaceuticals (60) | Uncategorized (8)
Recent Contracts
-
Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International
(Filed With SEC on February 8, 2021)
-
Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International
(Filed With SEC on November 5, 2020)
-
Base Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International
(Filed With SEC on November 5, 2020)
-
Amendment to the Amended and Restated Investor Agreement, dated as of May 25, 2020, by and among Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis US LLC, and Aventisub LLC
(Filed With SEC on May 29, 2020)
-
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 7, 2020)
-
Second Amendment Agreement, dated December 19, 2019, by and between Bayer HealthCare LLC and the Registrant
(Filed With SEC on February 7, 2020)
-
Investor Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc
(Filed With SEC on August 6, 2019)
-
Master Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc
(Filed With SEC on August 6, 2019)